Avastin 400 mg Injection (Bevacizumab) — Targeted Anti-Cancer Therapy Avastin 400 mg Injection contains bevacizumab, a targeted monoclonal antibody that inhibits vascular endothelial growth factor (VEGF) to cut off tumor blood supply, slowing tumor growth and helping manage advanced cancer. Commonly used in the treatment of metastatic colorectal cancer, non-small cell lung cancer (NSCLC), glioblastoma, renal cell carcinoma, cervical and ovarian cancers, Avastin is typically given as an intravenous infusion by trained oncologists. Due to its targeted mechanism, it is often combined with chemotherapy or other cancer therapies for enhanced effectiveness. Regular monitoring for blood pressure changes, bleeding, and kidney effects is required during treatment.